Diabetes Obes Metab. 2024 Mar 18. doi: 10.1111/dom.15552. Online ahead of print.
NO ABSTRACT
PMID:38497231 | DOI:10.1111/dom.15552
Categories
Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study
